Kilic, L. Et Al. 2018. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS. Congress of the European-League-Against-Rheumatism (EULAR) , (Amsterdam, Netherlands), 437-438.

Kilic, L., Karadag, O., Erden, A., Sari, A., Armagan, B., Firat, E., ... Kalyoncu, U.(2018). ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS . Congress of the European-League-Against-Rheumatism (EULAR) (pp.437-438). Amsterdam, Netherlands

Kilic, L. Et Al. "ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS," Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 2018

Kilic, L. Et Al. "ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.437-438, 2018

Kilic, L. Et Al. (2018) . "ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.437-438.

@conferencepaper{conferencepaper, author={L. Kilic Et Al. }, title={ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS}, congress name={Congress of the European-League-Against-Rheumatism (EULAR)}, city={Amsterdam}, country={Netherlands}, year={2018}, pages={437-438} }